01 / Vendor Profile
LAMPIRE BIOLOGICAL LABS INC Federal Contracts and Awards
UEI DYRWAJH2NK51 · CAGE 06LG8
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $1.81M in net contract obligations to LAMPIRE BIOLOGICAL LABS INC across 50 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
LAMPIRE BIOLOGICAL LABS INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$342.8K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $186.7K | 7 | 4 | — |
| FY 2021 | $202.5K | 9 | 4 | +8.5% |
| FY 2022 | $213.4K | 9 | 3 | +5.4% |
| FY 2023 | $284.2K | 8 | 5 | +33.2% |
| FY 2024 | $261.0K | 5 | 3 | −8.2% |
| FY 2025 | $314.5K | 5 | 3 | +20.5% |
| FY 2026 | $342.8K | 7 | 4 | +9.0% |
04 / Federal Customers
Which federal agencies buy from LAMPIRE BIOLOGICAL LABS INC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7523 | $1.66M | 17 | 91.7% | |
| 2100 | $46.1K | 8 | 2.6% | |
| 97DH | $43.1K | 5 | 2.4% | |
| 7524 | $34.9K | 1 | 1.9% | |
| 12H2 | $30.1K | 13 | 1.7% | |
| 12G2 | -$196 | 2 | 0.0% | |
| 7529 | -$4.6K | 4 | -0.3% |
05 / Contracting Offices
Which contracting offices buy from LAMPIRE BIOLOGICAL LABS INC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $1.66M | 17 | 91.7% | |
| W81XWH | DEPT OF THE ARMY | $46.1K | 8 | 2.6% | |
| HT9425 | DEFENSE HEALTH AGENCY (DHA) | $43.1K | 4 | 2.4% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $34.9K | 1 | 1.9% | |
| 12805B | AGRICULTURAL RESEARCH SERVICE | $26.6K | 10 | 1.5% | |
| 126612 | AGRICULTURAL RESEARCH SERVICE | $3.5K | 1 | 0.2% | |
| HT9426 | DEFENSE HEALTH AGENCY (DHA) | $0 | 1 | 0.0% | |
| 1232SA | AGRICULTURAL RESEARCH SERVICE | $0 | 1 | 0.0% | |
| 12405B | AGRICULTURAL RESEARCH SERVICE | -$40 | 1 | 0.0% | |
| 123A94 | FOOD SAFETY AND INSPECTION SERVICE | -$196 | 2 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $1.81M | 50 | 7 | 100.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 9430 | MISCELLANEOUS CRUDE ANIMAL PRODUCTS, INEDIBLE | $835.9K | 8 | 1 | 46.3% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | $544.5K | 11 | 3 | 30.2% |
| 6505 | DRUGS AND BIOLOGICALS | $284.6K | 2 | 2 | 15.8% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $70.1K | 8 | 2 | 3.9% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $30.9K | 6 | 4 | 1.7% |
| Q301 | MEDICAL- LABORATORY TESTING | $20.1K | 10 | 1 | 1.1% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $19.1K | 5 | 1 | 1.1% |
08 / Competition Pattern
How was LAMPIRE BIOLOGICAL LABS INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for LAMPIRE BIOLOGICAL LABS INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75F40126P00297 | Sep 28, 2026 | $34.9K | FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS | 325414 | 6640 |
10 / Interpreting the Profile
How should you evaluate LAMPIRE BIOLOGICAL LABS INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.